ATRIAL FIBRILLATION IN PATIENTS OF CERTAIN CLINICAL GROUPS: FEATURES OF PATHOGENESIS AND IMPACT ON CATHETER ABLATION TACTICS

Highlights In this review the authors have described the mechanism of atrial fibrillation (AF) development in patients with different comorbidity – in idiopathic AF, the AF concomitant to atrial hypertension and AF concomitant to ischemic heart disease. Currently, the treatment tactics for AF are based primarily on the duration of arrhythmia episodes, and not on the pathophysiological mechanisms of its development and progression. In our work, we tried to draw attention to the need for a pathogenetic view on the most common heart rhythm disease. Abstract The likelihood of atrial fibrillation occurrence increases with age and largely depends on the severity of concomitant cardiac and extracardiac pathology. In this review, we want to present an analysis of the data available in the literature on the pathogenesis and catheter treatment of atrial fibrillation in patients without visible structural and cardiovascular pathology (idiopathic atrial fibrillation), patients with hypertension and patients with coronary heart disease.